Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder

World Journal of Biological Psychiatry

Volumn 9, Issue 3, 2008, Pages 190-197

  Bozina, Nada ^a   Mihaljevic Peles, Alma ^a   Sagud, Marina ^a   Bilusic, Hrvoje ^b   Jakovljevic, Miro ^a  

^a KBC Zagreb   (Croatia)

^b Agency for Medicinal Products and Medical Devices   (Croatia)

Author keywords

Genetics; Major depressive disorder; Paroxetine; Serotonin transporter; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIHYPERTENSIVE AGENT; DIAZEPAM; DIURETIC AGENT; FLUOXETINE; FLUVOXAMINE; MAPROTILINE; ORAL ANTIDIABETIC AGENT; PAROXETINE; SEROTONIN TRANSPORTER; TRAZODONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAMILTON SCALE; HAPLOTYPE; HEREDITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PROMOTER REGION; STATISTICAL ANALYSIS; TREATMENT DURATION;

DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; PAROXETINE; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 48249094539     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.1080/15622970701308397     Document Type: Article

References (36)

1. Bozina, N., Medved, V., Rojnic Kuzman, M, Sain, I. and Sertic, J. (2006) Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients.
2. Bozina, N., Mihaljevic-Peles, A., Sagud, M., Jakovljevic, M. and Sertic, J. (2006) Serotonin transporter polymorphism in Croatian patients with major depressive disorder. 18, pp. 83-89.
3. Buchner, A., Erdfelder, E. and Faul, F.
4. Bradley, SL, Dodelzon, K., Sandhu, HK and Philbert, RA (2005) Relationship of serotonin transporter gene polymorphisms and haplotypes to mRNA transcription. 136, pp. 58-61.
5. Collier, DA, Stober, G. Li, T. et al. (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. 1, pp. 453-460.
6. Coyle, N., Jones, I., Robertson, E., Lendon, C. and Craddock, N. (2000) Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis. 356, pp. 1490-1491.
7. Durham, LK, Webb, SM, Milos, PM, Clary, CM and Seymour, AB (2004) The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. 174, pp. 525-529.
8. Fan, JB and Sklar, P. (2005) Meta-analysis reveals association between serotonin transporter gene STin2 VNTR polymorphism and schizophrenia. 10, pp. 928-938.
9. First, MB, Spitzer, RL, Gibbon, M. and William, JB (1996) American Psychiatric Association, Washington, DC
10. Hamilton, M. (1960) A rating scale for depression. 23, pp. 56-62.
11. Hanna, GL, Himle, JA Curtis, GC et al. (1998) Serotonin transporter and serotonin transporter promoter affects onset of paroxetine treatment seasonal variation in blood serotonin in families with obsessive-compulsive disorder. 18, pp. 102-111.
12. Heils, A., Teufel, A. Petri, S. et al. (1996) Allelic variation of human serotonin transporter gene expression. 66, pp. 2621-2624.
13. Hranilovic, D., Stefulj, J. Schwab, S. et al. (2004) Serotonin transporter promoter and intron 2 polymorphisms: Relationship between allelic variants and gene expression. 55, pp. 1090-1094.
14. Ito, K., Yoshida, K. Sato, K. et al. (2002) A variable number of tandem repeats in the serotonin transporter gene does not affects the antidepressant response to fluvoxamine. 111, pp. 235-239.
15. Kato, M., Ikenaga, Y. Wakeno, M. et al. (2005) Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism. 20, pp. 151-156.
16. Kim, DK, Lim, SW Lee, S. et al. (2001) Serotonin transporter gene polymorphism ant antidepressant response. 11, pp. 215-219.
17. Kirchheiner, J., Nickchen, K. Bauer, M. et al. (2004) Pharmacogenetic of antidepressants and antipsychotics: The contribution of allelic variations to the phenotype of drug response. 9, pp. 442-473.
18. Lesch, KP, Bengel, D. Heils, A. et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. 274, pp. 1527-1531.
19. MacKenzie, A. and Quin, J. (1999) A serotonin transporter gene intone 2 polymorphic regions, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. 96, pp. 15251-15255.
20. Mundo, E., Walker, M., Cate, T., Macciardi, F. and Kennedy, JL (2001) The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: Preliminary findings. 58, pp. 539-544.
21. Murphy Jr, GM, Hollander, SB, Rodrigues, HE, Kremer, C. and Schatzberg, AF (2004) Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. 61, pp. 1163-1169.
22. Perlis, RH, Mischoulon, D. Smoller, JW et al. (2003) Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. 54, pp. 879-883.
23. Perna, G., Favaron, E., Di Bella, D, Bussi, R. and Bellodi, L. (2005) Efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. 30, pp. 2230-2235.
24. Ramamoorthy, S., Mauman, AL Moore, KR et al. (1993) Antidepressant and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. 90, pp. 2542-2546.
25. Rauch, JL, Johnson, ME Fei, YJ et al. (2002) Initial conditions of serotonin transporter kinetics and genotype: Influence on SSRI trial outcome. 51, pp. 723-732.
26. Serretti, A. and Artioli, P. (2004) From molecular biology to pharmacogenetics: A review of the literature on antidepressant treatment and suggestions of possible candidate genes. 174, pp. 490-503.
27. Serretti, A., Zanardi, R., Cusin, C., Rossini, D., Lorenzi, C. and Smeraldi, E. (2001) Tryptophan hydroxylase gene associated with paroxetine antidepressant activity. 11, pp. 375-380.
28. Serretti, A., Kato, M., De Ronchi, D. and Kinoshita, T. (2006) Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients.
29. Smeraldi, E., Zanardi, R., Benedetti, F., Di Bella, D, Perez, J. and Catalano, M. (1998) Polymorphism within the promoter of the serotonin transporter gene andantidepressant efficacy of fluvoxamine. 3, pp. 508-511.
30. Smits, KM, Smits, LJM, Schouten, JSAG and Stelma, FF (2004) Influence of SERTPR and Stin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: A systematic review. 9, pp. 433-441.
31. Smeraldi, E., Benedetti, F. and Zanardi, R. (2002) Serotonin transporter promoter genotype and illness recurrence in mood disorders. 12, pp. 73-75.
32. Thase, ME, Entsuah, AR and Rudolph, RL (2001) Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. 178, pp. 234-241.
33. Yoshida, K., Ito, K. Sato, K. et al. (2002) Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients Progr Neuropsychopharmacol. 26, pp. 383-386.
34. Yoshida, K., Takahashi, H. Higuchi, H. et al. (2004) Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. 161, pp. 1575-1580.
35. Yu, YW-Y, Tsai, SJ, Chen, TJ, Lin, CH and Hong, CJ (2002) Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. 7, pp. 1115-1119.
36. Zanardi, R., Benedetti, F., Di Bella, D, Catalano, M. and Smeraldi, E. (2002) Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. 20, pp. 105-107.